These agents included anti-tumor drugs, such as vincristine, L733060, GW-843682X and cloforabine, as well as a haemostatic drug (hydrastine), a protein phosphatase inhibitor calyculin, the synthetic fluoxyprednisolone (triamcinolone), but also the cardiac glycosides digoxin and digitoxin and the PPARδ agonist L165041. The gene discussed is PPARD; the disease is neoplasm.